Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly Pops
Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs
Key Takeaways Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' weight-loss drugs in government-backed healthcare plans.The proposal recommended drugs like Ozempic and Mounjaro be covered under Medicare and Medicaid,
Eli Lilly Pops After Biden Proposes Medicare Cover Obesity Drugs. Is Lilly Stock A Buy?
Eli Lilly stock popped on news President Joe Biden proposed Medicare and Medicaid pay for weight-loss drugs. Is LLY stock a buy?
Novo Nordisk, Eli Lilly shares up as Biden proposes obesity coverage
Investors were excited as U.S. President Joe Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid. Novo called the move an important step forward for patients.
MarketWatch
16h
Eli Lilly & Co. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
17h
on MSN
These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Rivian, NRG Energy, Kohl’s, Semtech, and More
Shares of General Motors and Ford fall after President-elect Donald Trump announces his tariff plans, while Amgen tumbles as ...
2d
on MSN
Eli Lilly’s (LLY) Breakthroughs: Hedge Funds’ New Healthcare Favorite
We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...
1d
Eli Lilly Stock Is Rising Tuesday: What's Going On?
Eli Lilly And Co (NYSE:LLY) shares are trading higher Tuesday after the Biden-Harris Administration proposed a new rule to ...
23h
Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound
Amgen stock crashed Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's ...
3d
Eli Lilly: Steep Pullback, Still Compelling Here
LLY's recent sell-off presents a buying opportunity for savvy investors, with strong growth potential in the GLP-1 market ...
8d
'Nuclear Option'?: Eli Lilly Taps Big Law Firms in Federal Drug Pricing Dispute
The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program ...
The Motley Fool on MSN
7d
Is It Time to Sell Eli Lilly and Pfizer Stocks?
Pfizer also made a fortune with its oral COVID-19 therapy, Paxlovid.
Eli
Lilly
now ranks as the largest drugmaker in the ...
6d
Eli Lilly in pact with Chinese biotech for novel weight loss therapy
Eli Lilly (LLY) partners with Laekna Therapeutics to develop an obesity therapy that avoids muscle loss. Read more here.
ALS News Today
21h
Lilly to develop ALS therapies against targets ID’d with Verge tech
The Converge platform validated as many as 83% of its treatment targets in disease models, a higher success rate than usual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Joe Biden
Novo Nordisk
Amgen
U.S. Securities and Exchange Commission
Anti-obesity medication
Feedback